BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2715728)

  • 1. Interactions of sterols with antiestrogen-binding sites: structural requirements for high-affinity binding.
    Hwang PL; Matin A
    J Lipid Res; 1989 Feb; 30(2):239-45. PubMed ID: 2715728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites.
    Hwang PL
    Biochim Biophys Acta; 1990 Feb; 1033(2):154-61. PubMed ID: 2306459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
    Murphy PR; Butts C; Lazier CB
    Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of unsaturated fatty acids with anti-oestrogen-binding sites.
    Hwang PL
    Biochem J; 1987 Apr; 243(2):359-64. PubMed ID: 3632626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding sites in rat liver nuclei.
    Kon OL
    Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F; Rochefort H
    Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
    Martel C; Provencher L; Li X; St Pierre A; Leblanc G; Gauthier S; Mérand Y; Labrie F
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):199-205. PubMed ID: 9605415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
    de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of oxygenated sterols: positive correlation with binding affinities for the antiestrogen-binding sites.
    Lin L; Hwang PL
    Biochim Biophys Acta; 1991 Mar; 1082(2):177-84. PubMed ID: 2007181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
    Gray JM; Ziemian L
    Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.
    de Medina P; Silvente-Poirot S; Poirot M
    Autophagy; 2009 Oct; 5(7):1066-7. PubMed ID: 19738414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a triphenylethylene-antiestrogen-binding site on rat serum low density lipoprotein.
    Winneker RC; Guthrie SC; Clark JH
    Endocrinology; 1983 May; 112(5):1823-7. PubMed ID: 6832070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsaturated fatty acids as endogenous inhibitors of tamoxifen binding to anti-oestrogen-binding sites.
    Hwang PL
    Biochem J; 1986 Aug; 237(3):749-55. PubMed ID: 3800915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triphenylethylene antiestrogen binding sites (TABS) specificity.
    Clark JH; Mitchell WC; Guthrie SC
    J Steroid Biochem; 1987 Apr; 26(4):433-7. PubMed ID: 3586657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.